Known targets — ChEMBL curated mechanism
ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2BTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3MPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PPARGSLC6A2SLC6A3SLC6A4SMOTYK2pol
The experimentally established mechanism targets of Maleic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.47 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.43 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.43 |
| ▸ | MMP2 | P08253 | 2/20 | 0.42 |
| ▸ | MMP9 | P14780 | 2/20 | 0.42 |
| ▸ | CA12 | O43570 | 2/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | CA9 | Q16790 | 2/20 | 0.42 |
| ▸ | MMP1 | P03956 | 1/20 | 0.42 |
| ▸ | MMP3 | P08254 | 1/20 | 0.42 |
| ▸ | MMP8 | P22894 | 1/20 | 0.42 |
| ▸ | MMP13 | P45452 | 1/20 | 0.42 |
| ▸ | MAOA | P21397 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fumaric Acid SCHEMBL10697856 | 1.00 | ALDH1A1 (0.49) | ALDH1A1MAPTHDAC4HDAC3HDAC1 | |
| Fumaric Acid SCHEMBL10697849 | 1.00 | ALDH1A1 (0.49) | ALDH1A1MAPTHDAC4HDAC3HDAC1 | |
| Maleic Acid SCHEMBL10697842 | 1.00 | ALDH1A1 (0.49) | ALDH1A1MAPTHDAC4HDAC3HDAC1 | |
| SCHEMBL10699574 | 0.92 | HDAC4 (0.53) | HDAC4HDAC3HDAC1HDAC2MMP2 | |
| SCHEMBL9700012 | 0.92 | HDAC4 (0.53) | HDAC4HDAC3HDAC1HDAC2MMP2 | |
| SCHEMBL9700021 | 0.92 | HDAC4 (0.53) | HDAC4HDAC3HDAC1HDAC2MMP2 | |
| Hydrochloric Acid SCHEMBL9698872 | 0.90 | HDAC4 (0.52) | HDAC4HDAC3HDAC1HDAC2MMP2 | |
| Hydrochloric Acid SCHEMBL9700004 | 0.90 | HDAC4 (0.52) | HDAC4HDAC3HDAC1HDAC2MMP2 | |
| Maleic Acid SCHEMBL10698815 | 0.88 | HDAC4 (0.47) | ALDH1A1HDAC4MMP2MMP9CA12 | |
| SCHEMBL10698852 | 0.85 | HDAC4 (0.48) | ALDH1A1HDAC4HDAC3HDAC1HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0224566-A1 | ANTIARRHYTHMIC USE FOR AMINOCYCLOALKYLAMIDES | THE UPJOHN COMPANY (US) | 1987-06-10 | — | — | EP | claimed |
| WO-1986007257-A2 | ANTIARRHYTHMIC USE FOR AMINOCYCLOALKYLAMIDES | THE UPJOHN COMPANY (US) | 1986-12-18 | — | — | WO | claimed |
| EP-0263208-A2 | Antiarrhythmic use of aminocycloalkylamides | THE UPJOHN COMPANY (US) | 1988-04-13 | — | — | EP | disclosed |
| EP-0224566-A1 | ANTIARRHYTHMIC USE FOR AMINOCYCLOALKYLAMIDES | THE UPJOHN COMPANY (US) | 1987-06-10 | — | — | EP | disclosed |
| WO-1986007257-A2 | ANTIARRHYTHMIC USE FOR AMINOCYCLOALKYLAMIDES | THE UPJOHN COMPANY (US) | 1986-12-18 | — | — | WO | disclosed |